🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 1 month to go! Join CPE in Brussels for our three-day flagship event in Brussels, 25–27 June 2025! 🎯 Theme: Access for All – Bridging Inequalities in Cancer Care 🔗 Register now: lnkd.in/d-tmavcn 🔍 Discover more: lnkd.in/dkMTHsxp

📰 Traitements des tumeurs : qu’est-ce que l’ablation par micro-ondes ? À lire sur Harmonie Santé, le média qui prend soin de vous ⤵ harmonie-sante.fr/sante-soins/ma…

📰 En Égypte, le pari de Gustave Roussy qui ouvre son premier hôpital à l'international. À lire dans Les Echos ⤵ lesechos.fr/industrie-serv…

New drugs @ASCO2025 Gustave Roussy

🔥DESTINY-Breast09 (DB09) is one of most anticipated #ASCO25 presentations! Here a (⚠️cross-trial⚠️) PSF comparison of DESTINY-Breast07 (from FabriceAndre recent update at #ESMOTAT25) and CLEOPATRA, using LARVOL digitized KM plots DB09 raised the bar. The question is how high? 👀

TUXEDO-3 Trial #ASCO25 HER3-DXd shows interesting CNS activity in pts with: - Breast cancer active brain mts (after prior ADC and irrespective of subtype) - Lung cancer active brain mts - Leptomeningeal disease OncoAlert

Cheatsheet for SG vs Sac-TMT ADC properties and designs for various #ASCO25 presentations:

“ADCs have the potential to supplant chemotherapy & be 1st line treatment for all types of #breastcancer” Dr. Ian Krop #ASCO25 Bonadonna Lecture where he highlighted importance of mentorship & IITs to impact the future of cancer treatment ASCO OncoAlert Smilow Cancer Hospital

Special plenary for #DB09 at #ASCO25 🔥 PFS of 40.7 months vs 26.9 months (BIRC) or 40.7 vs 20.7 (by investigators) for patients on trastuzumab deruxtecan plus pertuzumab (T-DXd + P) vs. taxane, trastuzumab, and pertuzumab (THP) HR = 0.56

ABBV-400 a new antiMET ADC tested in pretreated EGFRm NSCLC reported ORR 26% and DoR 9.8 regardless cMET expression. It is a crowded space with BL-B01D1, DB-1310, dual TKI EGFR/ET etc. Can we ⬆️ ABBV-400 combining with osimertinib?TelisoV + Osi > Teliso alone in mEGFR 🫁#ASCO25

🔹 Suzette delaloge in prevention risk reduction and genetics session : finding the unseen: opportunities for early detection. #ASCO25 #ASCO

🔹 Le Dr Gazzah présente l'étude de phase 1 évaluant le stx-721 chez des patients avec cancers bronchiques et insertion EGFR exon 20. #ASCO25 #ASCO

🔹 ASCO: Exploring Low-dose immunotherapy regimens is feasible, and IO morning administration may enhance efficacy. Jordi Remon Masip #Immunotherapy #ASCO25 #ASCO

👨‍🎓 👩‍🎓 Les inscriptions au DU Radiobiologie et radioprotection appliquées à la radiothérapie sont ouvertes de Gustave Roussy et Université Paris-Saclay sont ouvertes. Inscrivez-vous pour mettre à jour vos connaissance sur la radiobiologie et la radioprotection.

Overview of ASCO 2025 Breast Cancer topics! #ASCO25 OncoAlert ASCO So many important topics.

La donna che vedete nell’immagine si chiama Rosa Donini. E a 104 anni, oggi, ha deciso di fare quello che Giorgia Meloni non vorrebbe che facessimo: si è recata alle urne. È uscita di casa, accompagnata da suo figlio, ha raggiunto il seggio, ha ritirato tutte e cinque le schede.

👩‍🎓 👨‍🎓 Les inscriptions au DU Carcinologie cervico-faciale de Gustave Roussy et Université Paris-Saclay Paris-Saclay sont ouvertes. Ce DU propose une mise à jour des connaissances pour la prise en charge de ces types de #cancers. Informations et inscription : tinyurl.com/ym2yzuh2

📰 Le Groupe TF1 renouvelle son engagement pour la recherche contre le cancer aux côtés de Gustave Roussy et de la Fondation ARC. Nous soutenir ➡ soutenir.gustaveroussy.fr/mobilisationca… Lire le communiqué de presse ➡ gustaveroussy.fr/fr/news-le-gro…

3rd year of a fantastic deep-dive workshop into #ADC development across solid tumors organized by ETOP IBCSG Partners Foundation amazing hosts Rolf Stahel and Solange Peters which is becoming a tradition! Happy to be invited among a stellar faculty of global experts across disciplines and

📰 Ce petit arrondi qui fait les grandes collectes. Découvrez l'expertise de Kim Leforestier et l'arrondi solidaire, un micro-don en caisse au profit des institutions telles que Gustave Roussy, dans Le nouvel Economiste ⤵ lenouveleconomiste.fr/lesdossiers/ce…